Keryx BiopharmaceuticalsKERX
13F holders, Q1 2024 (March 31)1holders
$3.00avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Keryx Biopharmaceuticals (KERX) in their 13F filings. The largest holder was Huntington National Bank ($3).
- Company
- Keryx Biopharmaceuticals
- CUSIP
- 492515101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Huntington National Bank | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is KERX's weight in each manager's 13F, not the share of Keryx Biopharmaceuticals the manager owns.